Omada Health has joined Eli Lilly's Employer Connect program to offer its GLP-1 Care Track, providing clinical evaluation, prescribing, and ongoing medication management for obesity treatment directly to employers. This partnership creates a new access pathway alongside existing pharmacy and cash-pay options, helping employers manage costs and provide coordinated lifestyle support with weight loss medications like Zepbound®. A recent Omada survey of over 3,000 GLP-1 patients revealed gaps in care and rising out-of-pocket costs, highlighting the need for better support beyond primary care. Omada’s program combines human-led care, technology, and personalized support to improve patient outcomes and help employers sustainably support obesity management.
